Stroke Prevention During Pregnancy: New Guidelines Highlight Critical Risks for Women

Why Are Pregnant and Postpartum Women at Higher Risk of Stroke?

Pregnancy triggers a cascade of cardiovascular changes that, while normal, can significantly increase stroke vulnerability. Blood volume increases by approximately 40–50%, cardiac output rises, and the coagulation system shifts toward a prothrombotic state to prepare for delivery. These adaptations, combined with conditions such as preeclampsia and gestational hypertension — which affect an estimated 5–10% of pregnancies worldwide according to the World Health Organization — create a substantially elevated risk for both ischemic and hemorrhagic stroke.

The American Heart Association has highlighted that pregnancy-related stroke incidence has been rising in recent decades, paralleling increases in maternal age, obesity, and chronic hypertension among women of reproductive age. Research published in the journal Stroke has shown that the risk is highest during the third trimester and the first six weeks postpartum, a period when hemodynamic stress peaks and the hypercoagulable state persists. Preeclampsia alone is estimated to double a woman's lifetime risk of stroke, making early detection and management of hypertensive disorders during pregnancy critical for long-term cardiovascular health.

What Are the Warning Signs of Stroke During Pregnancy?

Recognizing stroke in pregnant and postpartum women presents unique diagnostic challenges. Standard stroke symptoms such as sudden severe headache, visual disturbances, weakness on one side of the body, and difficulty speaking can overlap significantly with symptoms of preeclampsia and eclampsia. This overlap can lead to dangerous delays in diagnosis and treatment. The American Heart Association stresses that any sudden, severe neurological symptom in a pregnant or recently postpartum woman should prompt immediate stroke evaluation, including neuroimaging.

Acute ischemic stroke in pregnancy can be treated with intravenous alteplase (tPA), which does not cross the placenta in significant amounts according to available evidence reviewed by the AHA. However, clinicians have historically been hesitant to administer thrombolytics to pregnant patients due to bleeding concerns. Updated guidance encourages a multidisciplinary approach involving neurologists, obstetricians, and emergency physicians to ensure that eligible patients receive time-sensitive treatments. Mechanical thrombectomy is also considered safe and effective during pregnancy for large vessel occlusions, offering another critical treatment option.

How Can Stroke Risk Be Reduced Before, During, and After Pregnancy?

Prevention begins before conception. Women with pre-existing hypertension, diabetes, or a history of preeclampsia should work with their healthcare providers to optimize cardiovascular health prior to pregnancy. The U.S. Preventive Services Task Force recommends low-dose aspirin (81 mg daily) starting after 12 weeks of gestation for women at high risk of preeclampsia, a recommendation supported by evidence from large randomized trials showing a reduction in preeclampsia incidence of approximately 15–20%.

During pregnancy, regular blood pressure monitoring and prompt treatment of hypertensive disorders are essential. After delivery, the postpartum period requires continued vigilance — the AHA notes that many pregnancy-related strokes occur in the weeks following birth, when women may have reduced contact with healthcare providers. Long-term follow-up is equally important: women who experienced preeclampsia or gestational hypertension carry elevated cardiovascular risk for decades and should receive ongoing monitoring of blood pressure, lipids, and blood glucose as part of routine preventive care.